当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析 - 现金流量表

云南白药

(000538)

  

流通市值:985.26亿  总市值:991.69亿
流通股本:17.73亿   总股本:17.84亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金10,593,123,155.3443,254,436,486.5332,371,993,045.3922,091,374,463.95
收到的税费返还2,044,810.4413,465,000.88,177,680.735,182,541.29
收到其他与经营活动有关的现金235,594,818.38612,105,342.04492,241,373.25355,397,604.71
经营活动现金流入的平衡项目0000
经营活动现金流入小计10,830,762,784.1643,880,006,829.3732,872,412,099.3722,451,954,609.95
购买商品、接受劳务支付的现金7,845,521,579.731,321,052,292.3722,838,082,887.6315,211,108,311.76
支付给职工以及为职工支付的现金912,191,406.032,787,102,422.472,106,698,168.921,450,599,844.7
支付的各项税费440,181,224.182,490,279,928.721,835,654,339.611,217,056,511.47
支付其他与经营活动有关的现金919,271,014.62,984,569,043.542,018,837,957.871,311,572,550.03
经营活动现金流出的平衡项目0000
经营活动现金流出小计10,117,165,224.5139,583,003,687.128,799,273,354.0319,190,337,217.96
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额713,597,559.654,297,003,142.274,073,138,745.343,261,617,391.99
二、投资活动产生的现金流量:
收回投资收到的现金900,000,000553,145,988.513,145,988.513,145,988.51
取得投资收益收到的现金7,527,472.06420,227,984.66406,901,106.8669,197,636.37
处置固定资产、无形资产和其他长期资产收回的现金净额59,4202,832,9672,812,871262,565.39
处置子公司及其他营业单位收到的现金净额1,623,342.01---
收到的其他与投资活动有关的现金36,917,2007,043,006,5004,713,006,5003,807,040,500
投资活动现金流入的平衡项目0000
投资活动现金流入小计946,127,434.078,019,213,440.175,125,866,466.373,879,646,690.27
购建固定资产、无形资产和其他长期资产支付的现金125,862,941.89675,074,486.64446,401,375.38248,334,378.59
投资支付的现金650,040,0003,400,000,0001,400,000,000900,000,000
支付其他与投资活动有关的现金236,862,8005,143,140,0004,437,259,704.22,936,895,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,012,765,741.899,218,214,486.646,283,661,079.584,085,229,378.59
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-66,638,307.82-1,199,001,046.47-1,157,794,613.21-205,582,688.32
三、筹资活动产生的现金流量:
取得借款收到的现金-1,886,779,951.021,486,779,951.021,486,779,951.02
收到其他与筹资活动有关的现金16,000,439.3975,292,510.4351,565,263.7340,525,603.23
筹资活动现金流入平衡项目0000
筹资活动现金流入小计16,000,439.391,962,072,461.451,538,345,214.751,527,305,554.25
偿还债务支付的现金435,185,137.62,833,409,772.471,340,965,842.21869,283,674.87
分配股利、利润或偿付利息支付的现金5,778,093.195,951,560,088.743,744,008,284.963,731,518,655.97
其中:子公司支付给少数股东的股利、利润-8,040,928.52-5,974,218.23
支付其他与筹资活动有关的现金46,246,529.67154,837,764.12115,066,565.0972,018,152.38
筹资活动现金流出平衡项目0000
筹资活动现金流出小计487,209,760.468,939,807,625.335,200,040,692.264,672,820,483.22
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-471,209,321.07-6,977,735,163.88-3,661,695,477.51-3,145,514,928.97
四、汇率变动对现金及现金等价物的影响1,032,499.263,497,174.93-2,606,865.09-48,577.76
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额176,782,430.02-3,876,235,893.15-748,958,210.47-89,528,803.06
加:期初现金及现金等价物余额10,275,529,575.3414,151,765,468.4914,151,765,468.4914,151,765,468.49
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额10,452,312,005.3610,275,529,575.3413,402,807,258.0214,062,236,665.43
补充资料:
净利润-4,767,072,360.28-3,189,962,850.96
资产减值准备-131,156,636.24-86,340,929.65
固定资产和投资性房地产折旧-203,119,678.85-103,037,172.29
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-203,119,678.85-103,037,172.29
无形资产摊销-25,012,034.21-12,159,001.35
长期待摊费用摊销-38,404,127.2-19,405,792.34
处置固定资产、无形资产和其他长期资产的损失-435,663.65-1,592,134.63
固定资产报废损失--2,037,253.77-65,952.25
公允价值变动损失--136,837,009.94--4,596,876.81
财务费用-62,336,462.09-27,648,907.91
投资损失--842,061,414.65--477,498,314.49
递延所得税--47,010,547.79--90,787,456.62
其中:递延所得税资产减少--66,105,807.62--107,322,722.98
递延所得税负债增加-19,095,259.83-16,535,266.36
存货的减少-113,232,804.84-450,556,841.55
经营性应收项目的减少--758,018,810.16--739,995,094.96
经营性应付项目的增加-585,907,421.72-623,860,555.14
其他-72,926,421.01-17,450,377.13
现金的期末余额-10,275,529,575.34-14,062,236,665.43
减:现金的期初余额-14,151,765,468.49-14,151,765,468.49
公告日期2025-04-292025-04-012024-10-302024-08-27
审计意见(境内)标准无保留意见
TOP↑